This page is dedicated to the recruitment of participants for a clinical trial of an investigational product for inadequately controlled Asthma to be conducted by the University of the Sunshine Coast (QLD).
Full title: A Phase III, randomized, double-blind, active controlled, parallel group study, comparing the efficacy, safety and tolerability of the fixed dose combination FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled asthma.
You are invited to take part in this research project. This is because you have been diagnosed with Asthma.
The research project is testing the effectiveness and safety of a potential new triple therapy medicine to better manage and treat Asthma. Please complete the following survey to express interest in participating in the above-mentioned trial.
Please be aware that completion of the survey does not guarantee entry into the trial.
Ethics approval – Bellberry Limited
If you experience difficulty completing the survey please email email@example.com